Monday, January 30, 2012

Investopedia: Colgate-Palmolive Has Growth, But It'll Cost Ya


Perhaps there's nothing better today than a company that is logging very good growth with a set of products that are widely seen as economically-insensitive, day-to-day essentials. That has to be at least some of the explanation for the valuation of Colgate-Palmolive (NYSE:CL). For while this is absolutely an excellent company and a worthy buy-and-hold candidate for dividend-inclined investors, today's price is certainly no bargain.

Q4 Results - Good Growth, the Worst of the Margins?   
Colgate-Palmolive reported revenue growth of nearly 5%, with organic growth of 6% split evenly between volume and price. Oral/personal care (which is the overwhelming bulk of sales) had reported sales growth above 5%. By region, North America saw marginal growth (3.5%), while Europe was actually down 2% on an organic basis. Latin America and Asia/Africa both posted double-digit organic revenue growth. (For related reading, see Analyzing Operating Margins.)




Please click here for more:
http://stocks.investopedia.com/stock-analysis/2012/Colgate-Palmolive-Has-Growth-But-Itll-Cost-Ya-CL-PG-UL-JNJ0130.aspx

No comments: